Vivimed labs reported 49% decrease in quarterly profit on sequential basis

Myequity news service | Date : 30-05-2018 23:45:00 IST

Vivimed labs reported 49% decrease in quarterly profit on sequential basis. Company reported consolidated FY18-Q4 profit of Rs 10.76 crores compared to Rs. 21.13 crores in FY18-Q3. Revenue in the same period decreased by 4.69%.

Snapshot of quarterly earnings:

Below are the highlights of full year consolidated report:

  • Total Income reduced by 5.17% from Rs 1,258.10* crores to Rs 1185.7 crores.
    * Excluding the onetime gain from sale of Klarsen to Clariant

  • Reported net profit of Rs. 75.43 crores, decreased by 11.47% compared to previous year.

  • Total debt decreased to Rs. 777 crores.

  • 12-month EPS decreased by 2.36% to Rs 9.11.

  • Board of directors recommended dividend of Rs. 0.40/Share.

Results were announced post market hours, stock closed at Rs. 61.50 up 0.16% on 30-May-2018.


More from Myequity